📣 VC round data is live. Check it out!
- Public Comps
- Brain+
Brain+ Valuation Multiples
Discover revenue and EBITDA valuation multiples for Brain+ and similar public comparables like Clarent, Premier Health Of America, Omni Health, Binovi Technologies and more.
Brain+ Overview
About Brain+
Brain+ AS is a digital therapeutics company. It is focused on developing and commercializing solutions for dementia care and with a primary focus on Cognitive Stimulation Therapy (CST). The company has developed a set of Digital Medicine technologies. Its product pipeline includes CST Therapist Companion, and CST Home Companion; CST Home Care; CST for Mild Cognitive Impairment (MCI). The company is developing Ayla, a scalable dementia care platform that provides software-based therapy and care solutions designed to support individuals with dementia.
Founded
2012
HQ

Employees
12
Website
Sectors
Financials (FY)
Market Cap
$461K
Valuation Multiples
Start free trialBrain+ Stock Performance
Brain+ has current market cap of $461K.
Market Cap Evolution
Brain+'s stock price is $0.00.
Brain+ share price decreased by 70.8% in the last year.
| Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|
| $461K | 0.0% | - | - | -70.8% | - |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialBrain+ Valuation Multiples
Brain+ Financial Valuation Multiples
As of June 2, 2026, Brain+ has market cap of $461K.
| LTM | Last FY | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Brain+ Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Brain+ Competitors
Brain+ competitors include Clarent, Premier Health Of America, Omni Health, Binovi Technologies, Alternate Health, 1933 Industries, Medondo Holding, Monsenso, Aino Health and Telemedycyna Polska.
Most Brain+ public comparables operate across Digital Therapeutics, Health Data & Analytics, Healthcare Software, B2B SaaS, HealthTech and Vertical SaaS.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| - | - | - | - | |||
| 0.4x | 0.4x | (12.3x) | - | |||
| - | - | - | - | |||
| - | - | - | - | |||
| - | - | - | - | |||
| 1.0x | - | 17.5x | - | |||
| 3.8x | - | (5.6x) | - | |||
| 2.0x | - | (5.9x) | - | |||
This data is available for Pro users. Sign up to see all Brain+ competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Brain+
| When was Brain+ founded? | Brain+ was founded in 2012. |
| Where is Brain+ headquartered? | Brain+ is headquartered in Denmark. |
| How many employees does Brain+ have? | As of today, Brain+ has over 12 employees. |
| Is Brain+ publicly listed? | Yes, Brain+ is a public company listed on Nasdaq Copenhagen. |
| What is the stock symbol of Brain+? | Brain+ trades under BRAINP ticker. |
| When did Brain+ go public? | Brain+ went public in 2021. |
| Who are competitors of Brain+? | Brain+ main competitors include Clarent, Premier Health Of America, Omni Health, Binovi Technologies, Alternate Health, 1933 Industries, Medondo Holding, Monsenso, Aino Health, Telemedycyna Polska. |
| What is the current market cap of Brain+? | Brain+'s current market cap is $461K. |
| Is Brain+ profitable? | No, Brain+ is not profitable. |
| How many companies Brain+ has acquired to date? | Brain+ hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Brain+ has invested to date? | Brain+ hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Brain+
Lists including Brain+
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.